Cognetivity Neurosciences is a medical technology company developing an AI platform for early detection of cognitive impairment, dementia and Alzheimer's disease.
Our patented rapid cognitive analysis technology aims to make early detection a reality, and aims to bring the benefits of being: easier to administer, more accessible, less expensive, allowing earlier and more accurate diagnosis.
Company Details
- Employees
- 9
- Founded
- -
- Address
- 3, Waterhouse Square, 138 Holborn, London,greater London Ec1n 2sw,united Kingdom
- Industry
- Health, Wellness & Fitness
- Website
- cognetivity.com
- Keywords
- Artificial Intelligence, Medical Devices, Diagnostics, Health Monitoring, SaMD, Digital Health, Cognitive Assessment, Neuroscience, Dementia, Technology, Diagnosis, Alzheimer's Disease.
- HQ
- London, Greater London
Cognetivity Neurosciences Ltd Questions
Cognetivity Neurosciences Ltd's website is cognetivity.com
Cognetivity Neurosciences Ltd's LinkedIn profile is https://uk.linkedin.com/company/cognetivity
Cognetivity Neurosciences Ltd has
9 employees.
View email and phone details for 9
employees at Cognetivity Neurosciences Ltd.
Cognetivity Neurosciences Ltd's industry is
Health, Wellness & Fitness
Cognetivity Neurosciences Ltd's top competitors are
Cognetiq,
Ascend Solutions,
Investbridge Capital,
Cambridge Cognition,
Tympahealth Technologies Ltd,
Theseus Capital Ltd,
Oracle,
Cantabio Pharmaceuticals, Inc.,
Ge Healthcare,
Uk Health Security Agency.
Cognetivity Neurosciences Ltd's categories are Health, Wellness & Fitness
Cognetivity Neurosciences Ltd's founding year is 2013
